Literature DB >> 25363574

Serum vitamin D levels are inversely related with non-alcoholic fatty liver disease independent of visceral obesity in Chinese postmenopausal women.

Zhigang Lu1, Xiaoping Pan, Yaqin Hu, Yaping Hao, Yuqi Luo, Xiang Hu, Xiaojing Ma, Yuqian Bao, Weiping Jia.   

Abstract

The aim of the present study was to investigate the association between serum vitamin D levels and both visceral adipose and with non-alcoholic fatty liver disease (NAFLD) in Chinese postmenopausal women. Four hundred and fifty-one postmenopausal women between 45 and 74 years of age (mean (± SD) age 57.3 ± 4.6 years) were enrolled in the study. All subjects participated in the Shanghai Obesity Study between June and August 2011 and underwent abdominal magnetic resonance imaging and an abdominal ultrasonography. Patients with a visceral fat area (VFA) ≥ 80 cm(2) were classified as abdominally obese. Serum 25-hydroxyvitamin D3 (25(OH)D3 ) levels were measured with an electrochemiluminescence immunoassay. The prevalence of NAFLD in the study population was 34.8% (n = 157). Women with abdominal obesity had significantly lower serum 25(OH)D3 levels than those without abdominal obesity (median (interquartile range) 11.23 (8.64-14.12) vs 12.56 (9.41-15.98) ng/mL, respectively; P < 0.01). Regardless of abdominal obesity status, serum 25(OH)D3 levels in patients with NAFLD were lower than those without non-NAFLD (11.14 (8.63-13.81) vs 12.92 (9.48-16.37) ng/mL (P < 0.05) for those without abdominal obesity; 10.86 (8.61-13.56) vs 11.55 (8.82-16.38) ng/mL (P < 0.05) for those with abdominal obesity). Partial correlation analyses demonstrated a negative correlation between serum 25(OH)D3 levels and VFA (P < 0.05). Logistic regression analysis revealed that high serum 25(OH)D3 levels were a protective factor against NAFLD after adjusting for risk factors such as VFA. In conclusion, independent of visceral obesity, vitamin D is inversely correlated with NAFLD in Chinese postmenopausal women.
© 2014 The Authors. Clinical and Experimental Pharmacology and Physiology published by Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  non-alcoholic fatty liver disease; visceral obesity; vitamin D

Mesh:

Substances:

Year:  2015        PMID: 25363574     DOI: 10.1111/1440-1681.12334

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  8 in total

1.  Serum 25-hydroxyvitamin-D and nonalcoholic fatty liver disease: Does race/ethnicity matter? Findings from the MESA cohort.

Authors:  Samar R El Khoudary; Saad Samargandy; Irfan Zeb; Temitope Foster; Ian H de Boer; Dong Li; Matthew J Budoff
Journal:  Nutr Metab Cardiovasc Dis       Date:  2019-09-10       Impact factor: 4.222

2.  Calcium and vitamin D3 combinations improve fatty liver disease through AMPK-independent mechanisms.

Authors:  Sara Shojaei Zarghani; Hamid Soraya; Mohammad Alizadeh
Journal:  Eur J Nutr       Date:  2016-12-17       Impact factor: 5.614

3.  Association and interaction between vitamin D level and metabolic syndrome for non-alcoholic fatty liver disease.

Authors:  Salam Bennouar; Abdelghani Bachir Cherif; Amel Kessira; Djamel Eddine Bennouar; Samia Abdi
Journal:  J Diabetes Metab Disord       Date:  2021-07-21

4.  Correlational study on the levels of 25-hydroxyvitamin D and non-alcoholic fatty liver disease in type 2 diabetic patients.

Authors:  Yuanyuan Zhang; Juyi Li; Yingqun Ni; Yan Wang; Huaizhen Liu
Journal:  BMC Endocr Disord       Date:  2021-05-18       Impact factor: 2.763

5.  Is Vitamin D an Independent Risk Factor of Nonalcoholic Fatty Liver Disease?: a Cross-Sectional Study of the Healthy Population.

Authors:  Danbee Park; Hyuktae Kwon; Seung Won Oh; Hee Kyung Joh; Seung Sik Hwang; Jin Ho Park; Jae Moon Yun; Hyejin Lee; Goh Eun Chung; Sangjoon Ze; Jae Hong Park; Yeseul Bae; Arang Lee
Journal:  J Korean Med Sci       Date:  2017-01       Impact factor: 2.153

6.  Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift.

Authors:  A Drori; D Rotnemer-Golinkin; S Avni; A Drori; O Danay; D Levanon; J Tam; L Zolotarev; Y Ilan
Journal:  BMC Gastroenterol       Date:  2017-11-28       Impact factor: 3.067

Review 7.  The Level of Vitamin D in Children and Adolescents with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.

Authors:  Shanshan Zhu; Yuhui Wang; Fei Luo; Jie Liu; Liangchang Xiu; Jiheng Qin; Tao Wang; Na Yu; Hongfu Wu; Tangbin Zou
Journal:  Biomed Res Int       Date:  2019-07-14       Impact factor: 3.411

8.  Efficacy of vitamin D supplement in children with nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis.

Authors:  Jie Liu; Tingting Wang; Junmin Chen; Yanli Zhang; Xiaoqin Yin; Xueqin Fan; Qiu Chen
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.